Literature DB >> 22013222

Hepatitis C transmission in injection drug users: could swabs be the main culprit?

Vincent Thibault1, Jean-Louis Bara, Thomas Nefau, Catherine Duplessy-Garson.   

Abstract

Prevention programs for intravenous drug users have proven their efficacy in decreasing human immunodeficiency virus transmission but have limited effect on hepatitis C virus (HCV) contamination. A study was conducted to document the presence of HCV genome (HCV RNA) in 620 items of used injecting paraphernalia collected from representative sites. Using sensitive molecular techniques, HCV RNA was not detected on used filters or water vials and was seldom detected on cups (9%). However, HCV RNA was frequently found on syringe pools (38%) and on swabs (82%) at high titers. Our investigation, which was conducted in real injecting settings, highlights swabs as a potential source for HCV transmission.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22013222     DOI： 10.1093/infdis/jir650

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Hepatitis C virus vaccines among people who inject drugs.

Authors:  Andrea L Cox; David L Thomas
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

2.  6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection-What are the remaining gaps?

Authors:  Sarwat Khan; Annie Bernier; Dustin Dapp; Emmanuel Fortier; Mel Krajden; Alexandra King; Jason Grebely; Selena M Sagan; Curtis L Cooper; Angela M Crawley
Journal:  Can Liver J       Date:  2018-07-17

3.  Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.

Authors:  David Otiashvili; Gvantsa Piralishvili; Zura Sikharulidze; George Kamkamidze; Sabrina Poole; George E Woody
Journal:  Drug Alcohol Depend       Date:  2013-07-31       Impact factor: 4.492

4.  Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.

Authors:  Juliane Doerrbecker; Patrick Behrendt; Pedro Mateu-Gelabert; Sandra Ciesek; Nina Riebesehl; Corinne Wilhelm; Joerg Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  J Infect Dis       Date:  2012-11-05       Impact factor: 5.226

5.  Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden.

Authors:  Axel Danielsson; Navaneethan Palanisamy; Sultan Golbob; Hong Yin; Jonas Blomberg; Johan Hedlund; Staffan Sylvan; Johan Lennerstrand
Journal:  Infect Ecol Epidemiol       Date:  2014-01-15

Review 6.  Ending hepatitis C in the United States: the role of screening.

Authors:  Phillip O Coffin; Andrew Reynolds
Journal:  Hepat Med       Date:  2014-07-03

7.  Clinical Characteristics and Treatment Efficasy of Chronic HCV Infection Among Intravenous Drug Users in Tuzla Canton.

Authors:  Jasminka Petrovic; Nermin Salkic; Dilista Piljic; Sead Ahmetagic; Rahima Jahic; Humera Porobic; Arnela Smriko-Nuhanovic; Mevludin Hasanovic
Journal:  Mater Sociomed       Date:  2018-12

8.  HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service.

Authors:  Magally Torres-Leguizamon; Emmanuel G Reynaud; Thomas Néfau; Catherine Duplessy
Journal:  Harm Reduct J       Date:  2020-08-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.